Attorney General Todd Rokita releases statement on Biden vaccine mandates
Following unprecedented Federal mandates upon the private sector being announced last evening by US President Joe Biden, the Indiana Attorney General announced the following brief statement:
“My team and I, along with other like-minded attorneys general, are reviewing all legal action on how to stand against these authoritarian actions by the Biden administration.
“We will be prepared to file suit if Biden seeks illegal actions restricting Hoosiers’ liberties.”
Indiana Lady Hoosiers ranked Pre-season #8
The IU Women’s Basketball team did not disappoint last year, going 21-6 and making it to the Elite 8 round of the NCAA Tournament. Sadly, the ran into an overpowering Arizona team, which would eventually become the National Runner-up. Although, the returning of all 5 starters has landed plenty of eyes on Bloomington’s gem of a team. NCAA.com has the Hoosiers ranked #8 in Autumn Johnson’s recent Power Rankings. This is the first time IU has broken a top ten national ranking.
The list includes 3 Big 10 Women’s Basketball teams, which will make for expectedly exciting season this year! Here are the rankings:
- South Carolina
- UCONN
- Stanford
- Maryland
- NC State
- Louisville
- Oregon
- Indiana
- Iowa
- Baylor
Indiana Medicaid recovers $1.8 million under national settlement with Bristol-Myers Squibb Co.
Attorney General Todd Rokita announced today that Indiana Medicaid has recovered $1.8 million as part of a $75 million national civil settlement resolving allegations that Bristol-Myers Squibb Co. overcharged state Medicaid programs for drugs. Of the $1.8 million, $746,780 goes directly to the state, and the remainder goes to the U.S. federal government. The Medicaid program is administered jointly by the federal government and the individual states.
Bristol-Myers Squibb, a New York-based pharmaceutical manufacturer, settled with the states and the federal government following an investigation arising from a whistleblower action filed in the U.S. District Court for the Eastern District of Pennsylvania under the federal False Claims Act and various state false claims statutes. Specifically, these settlements resolve allegations that Bristol-Myers Squibb misreported sales figures and underpaid drug rebates owed to the states. Under a federal law known as the Medicaid Drug Rebate Program, drug manufacturers must periodically return a portion of the amount paid by state Medicaid programs for the manufacturers’ drugs. The effect of these accounting practices, the whistleblower alleged, was to falsely decrease the average price the companies reported to the federal government and improperly decrease the rebates paid to the states.
The claims resolved by the settlement are allegations only; there has been no determination of liability.